FDA approves Moderna’s mRNA-based vaccine for the flu
Global News Canada · Published 1h ago
The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.
GlobeSignal
Health Alert
Public health developments like this can directly affect healthcare decisions and guidance.
GlobeSignal: A transparent, keyword-based read on this story's tone and stakes—not financial, political or safety advice. The summary above is the original publisher's excerpt, not AI-generated or rewritten by GlobeVerge. Open the original source link before acting on any story.